Vivid Vision
Vivid Vision develops VR-based vision care software for treating binocular vision disorders (amblyopia, strabismus, convergence insufficiency) and provides clinical-trial-grade visual field testing endpoints for ophthalmic pharmaceutical companies. Sold through a global network of licensed eye care professionals.
- Company typePrivate
- Founded2014
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Vivid Vision does
Vivid Vision is a privately-held digital health company founded in 2014 and headquartered in San Francisco, with a wholly-owned subsidiary in Tokyo (Vivid Vision Asia, Inc.). The company develops a VR-based vision care platform with three core products: Vivid Vision Clinical (in-office VR training for licensed eye care professionals), Vivid Vision Home (prescribed at-home VR therapy), and Vivid Vision Perimetry (VVP), an ultra-precise VR-based visual field testing system used as a digital endpoint in ophthalmic clinical trials for geographic atrophy, AMD, and glaucoma. Underlying technology uses head-mounted displays with dichoptic stimulation for binocular vision therapy and natural-fixation perimetry with lesion-customized stimulus placement for retinal assessment, achieving 6.8x better precision than Standard Automated Perimetry.
The business model is a B2B provider-network model with two distinct revenue streams. In the clinical vertical, Vivid Vision licenses software subscriptions to licensed optometrists, ophthalmologists, and vision therapy clinics who prescribe treatment to patients; patients typically pay providers $700-$1,200 per 3-month program, with Vivid Vision capturing a software licensing slice. The company also sells DPVR P1 Pro VR headsets (with Vivid Vision Home pre-installed) exclusively to providers through its online store. Distribution is direct in the US with regional resellers in the EU/UK (VISUS), Mexico (optirepresentaciones), and Asia. In the biopharma vertical, Vivid Vision sells VVP as a clinical-trial endpoint service to large ophthalmic pharmaceutical companies, anchored by a Regeneron-sponsored validation study at the Retina Foundation of the Southwest. As of 2025, the company reports 100,000+ patients treated across 50+ countries, FDA Class I medical device registration, CE Mark certification, and HIPAA/GDPR compliance.
Vivid Vision firmographics
Firmographics- Name
- Vivid Vision
- Legal name
- Vivid Vision, Inc.
- Website
- https://seevividly.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vivid Vision develops VR-based vision care software for treating binocular vision disorders (amblyopia, strabismus, convergence insufficiency) and provides clinical-trial-grade visual field testing endpoints for ophthalmic pharmaceutical companies. Sold through a global network of licensed eye care professionals.
- Ownership category
- akta.pro rank
Vivid Vision industry classification
Industry- Product category
- VR-based vision therapy software
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Ophthalmic Goods (3851)
- akta.pro primary industry
- VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics) (MPAFAGAG)
Keywords
Where Vivid Vision is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Vivid Vision business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Subscriptions (Clinical): Vivid Vision Clinical software licensed to eye care professionals for in-office treatment. Requires active provider account and is sold through direct sales and distributor networks. Pricing varies by geographic location, provider experience, and treatment plan complexity.
- Software Subscriptions (Home): Vivid Vision Home software prescribed by providers to patients for at-home vision therapy exercises. Sold in license pools to providers who then manage patient access. Patients pay through their vision therapy program costs ($700-$1200 for 3 months per patient reports).
- Hardware Sales: VR headsets sold through Vivid Vision online store. Commercial-grade DPVR P1 Pro headset comes pre-installed with Vivid Vision Home software and is available exclusively to providers, not consumers.
- EYEBAB VT Distribution: Distribution partnership for EYEBAB vision therapy software in USA and Canada, bringing in additional software licensing revenue through Vivid Vision's provider network.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Vivid Vision Clinical - In-office treatment system |
| Subscription | Monthly | Vivid Vision Home - At-home vision therapy |
| One time/ perpetual license | One time/ perpetual license | VR Hardware (DPVR P1 Pro) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Vivid Vision product offering
Product offeringCore offering
Vivid Vision develops VR-based software for vision care, sold to licensed eye care professionals for in-office and at-home treatment of amblyopia, strabismus, and convergence insufficiency, plus clinical-grade VR perimetry used as endpoints in ophthalmic clinical trials. The company licenses its Vivid Vision Clinical and Vivid Vision Home platforms to providers, distributes pre-configured VR headsets, and operates a provider network across 50+ countries.
Product overview
Vivid Vision offers a suite of VR-based vision care products consisting of Vivid Vision Clinical (in-office vision training system for eye care professionals), Vivid Vision Home (prescribed at-home vision therapy via web application), and Vivid Vision Perimetry (VR-based perimetry for clinical trials). The company also distributes EYEBAB VT as a supplementary vision therapy module. Vivid Vision treats conditions including amblyopia, strabismus, and convergence insufficiency using dichoptic VR technology that presents different images to each eye to train binocular vision.
Differentiator
Problem solved
Functional benefit
Brands
- Vivid Vision Perimetry (VVP): Ultra-precise visual field testing solution for clinical trials, used for AMD, GA, and glaucoma endpoints
- EYEBAB VT
- Vivid Vision Clinical
- Vivid Vision Home
Products and services
- Vivid Vision Clinical In-office vision training system for licensed eye care professionals (optometrists and ophthalmologists) that uses VR to assess and treat amblyopia, strabismus, convergence insufficiency, and other binocular vision disorders with room-scale VR exercises and sports vision training.
- Vivid Vision Home Web-based at-home vision therapy application prescribed by licensed eye care providers, allowing patients to perform dichoptic VR therapy exercises on their own schedule from home using compatible VR headsets.
- Vivid Vision Perimetry (VVP) Ultra-precise VR-based visual field testing system with natural fixation and lesion-customized stimulus grids, used as a targeted microperimetry endpoint in clinical trials for geographic atrophy, AMD, and glaucoma. Provides 6.8x better precision than standard automated perimetry.
- EYEBAB VT Vision therapy software distributed by Vivid Vision in US and Canada offering dozens of vision activities and visual processing exercises including consensus, reaction time, concentration, endurance, and memory training for post-concussion and vision rehabilitation.
- Vivid Vision Perimetry Digital Endpoints Targeted microperimetry-based digital endpoints used in clinical trials for geographic atrophy, AMD, and glaucoma, providing 6.8x better precision than SAP and 2x better fixation stability, accelerating pharmaceutical trial timelines.
- DPVR P1 Pro VR Headset Commercial-grade VR headset pre-installed with Vivid Vision Home software, sold exclusively to licensed providers through the Vivid Vision online store as the recommended headset for patient home use.
Quantifiable outcome
- 6.8x better precision than Standard Automated Perimetry (SAP)
- +4 more outcomes
Companies that use Vivid Vision
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
Vivid Vision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Vivid Vision partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- VSP VisioncoreVivid Vision selected as finalist for VSP Vision Innovation Challenge 2025, a global competition hosted by VSP Vision, MATTER healthcare incubator, and Topcon Healthcare. Chief Growth Officer Kelin Kushin presented the company's solution at Vision Expo West. The partnership provides mentorship, industry connections, and market exposure within the vision care ecosystem.
- RegeneroncoreRegeneron sponsored the landmark study by Dr. Karl Csaky at Retina Foundation of the Southwest demonstrating that at-home VR-based vision testing matches the accuracy of in-clinic microperimetry while providing greater precision. The study validated Vivid Vision Perimetry for use in geographic atrophy clinical trials.
- EYEBAB ApScoreDistribution agreement signed November 26, 2020 for EYEBAB vision therapy software in USA and Canada. EYEBAB specializes in digital vision training apps for people with vision and concentration difficulties, including post-concussion rehabilitation. Vivid Vision's large professional network distributes EYEBAB's platform, which includes training for consensus, reaction time, concentration, endurance, and memory.
- MATTER Healthcare IncubatorminorMATTER provided expert mentorship, pitch deck support, and exclusive resources during the four-week startup bootcamp as part of the VSP Innovation Challenge 2025.
- Topcon HealthcareminorCo-host of the VSP Vision Innovation Challenge 2025, providing industry expertise and connections within the vision care technology space.
- Retina Foundation of the SouthwestcorePremier research institution led by Dr. Karl Csaky that conducted the pivotal study validating Vivid Vision Perimetry. The foundation was the first site to evaluate VVP tests in patients with Geographic Atrophy and presented findings at Macula Society.
- Duke University Medical CenterminorDr. Eleonora Lad, MD, PhD, Vice Chair of Clinical Research, Ophthalmology, serves as a key opinion leader endorsing Vivid Vision Perimetry as an endpoint in clinical trials for bringing sight-saving therapeutics to market.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Vivid Vision competitors and assessment
Company assessmentEmerging players
- AmblyoPlay: AmblyoPlay provides gamified at-home vision therapy software for amblyopia and other binocular conditions, competing with Vivid Vision Home on patient-facing, prescribed vision therapy programs.
- Bynocs: Bynocs offers cloud-based binocular vision therapy software used by optometrists for amblyopia, strabismus, and vergence disorders, with a clinical B2B model similar to Vivid Vision Clinical but delivered via screen-based rather than fully immersive VR.
- RevitaVision: RevitaVision provides office-based and home-based vision therapy software for binocular vision disorders, addressing the same optometric practice channel as Vivid Vision Clinical with an alternative digital workflow.
Broad incumbents
- Topcon Healthcare: Topcon Healthcare is a major incumbent in ophthalmic diagnostic imaging and perimetry (e.g., MAIA microperimetry), making it both a potential competitor and partner in the retinal clinical-trial endpoint space where Vivid Vision Perimetry competes.
- Carl Zeiss Meditec: Zeiss Meditec manufactures Humphrey Field Analyzers, the dominant standard automated perimetry (SAP) devices that VVP benchmarks against. As the incumbent in visual field testing, it represents the primary technology competitor for the perimetry business.
- Haag-Streit: Haag-Streit manufactures ophthalmic diagnostic equipment including perimetry devices used in eye care practices, making it an adjacent incumbent in the visual field testing market that Vivid Vision Perimetry targets.
Direct peers
- Luminopia: Luminopia develops FDA-cleared dichoptic VR therapy for amblyopia in children and is a direct competitor to Vivid Vision, including head-to-head testing in the NIH-funded PEDIG pediatric amblyopia trials. Both companies target the same patient population and provider channel with VR-based binocular vision therapy.
- CureSight: CureSight (by NovaSight) provides at-home digital vision therapy for amblyopia using eye-tracking and binocular training, directly overlapping with Vivid Vision Home on patient use cases and provider prescription workflows.
- NovaSight: NovaSight offers eye-tracking-based digital vision therapies and diagnostics, including amblyopia treatment products that compete with Vivid Vision Clinical and Home. It targets the same optometrist/ophthalmologist provider base with VR/AI-based pediatric vision solutions.
Others
- DPVR: DPVR is the VR headset manufacturer whose DPVR P1 Pro is sold pre-loaded with Vivid Vision Home through Vivid Vision's online store, making it a key hardware partner and ecosystem dependency for the home therapy product.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Vivid Vision social profiles
Digital presenceVivid Vision compliance and trust
Trust signalCompliance5 records
Vivid Vision financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vivid Vision leadership team
Management profileNumber of profiles
Profiles5 records
Vivid Vision subsidiaries and ownership
Company hierarchySubsidiaries1 record
Vivid Vision funding detail
Funding detailFunding overview
Funding rounds5 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vivid Vision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vivid Vision
What does Vivid Vision do?
Vivid Vision develops VR-based software for vision care, sold to licensed eye care professionals for in-office and at-home treatment of amblyopia, strabismus, and convergence insufficiency, plus clinical-grade VR perimetry used as endpoints in ophthalmic clinical trials. The company licenses its Vivid Vision Clinical and Vivid Vision Home platforms to providers, distributes pre-configured VR headsets, and operates a provider network across 50+ countries.
Is Vivid Vision a public or private company?
Vivid Vision is a private company. It is classified as venture growth investor backed and is currently operating.
When was Vivid Vision founded?
Vivid Vision was founded in 2014. It employs 11 to 50 people.
Where is Vivid Vision based?
Vivid Vision is headquartered in San Francisco, United States, in the North America region.
How does Vivid Vision make money?
Four revenue lines are on record. Software Subscriptions (Clinical) is the primary driver. The others are software Subscriptions (Home), hardware Sales and EYEBAB VT Distribution.
Who are Vivid Vision's main competitors?
Emerging players on record are AmblyoPlay, Bynocs and RevitaVision. Broad incumbents are Topcon Healthcare, Carl Zeiss Meditec and Haag-Streit. Direct peers are Luminopia, CureSight and NovaSight. DPVR is listed as an others.
Does Vivid Vision have an API?
No public API is recorded for Vivid Vision.
What industry is Vivid Vision in?
Vivid Vision's product category is VR-based vision therapy software. Its primary akta.pro industry code is MPAFAGAG, VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics). Its NAICS code is 339115 and its SIC code is 3851.